Experienced in Multiple Myeloma

Jean P. Roy

Montreal, QC, CA 
Experienced in Multiple Myeloma
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Jean Roy practices in Montreal, Canada. Ms. Roy is rated as an Experienced expert by MediFind in the treatment of Multiple Myeloma. Her top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Febrile Neutropenia, Multiple Myeloma, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 41 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 11 articles and participated in 2 clinical trials in the study of Multiple Myeloma.

Gender
Female

Locations

Montreal, QC H1T2M4, Canada
Other Locations
Montreal, Canada
Quebec, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
Enrollment Status: Active_not_recruiting
Publish Date: June 29, 2025
A Phase II, Open-label Study of Bortezomib Following Nonmyeloablative Allogeneic Stem Cell Transplant in Patients With High-risk Multiple Myeloma
A Phase II, Open-label Study of Bortezomib Following Nonmyeloablative Allogeneic Stem Cell Transplant in Patients With High-risk Multiple Myeloma
Enrollment Status: Completed
Publish Date: October 19, 2023
Intervention Type: Drug
Study Drug: Bortezomib Following Nonmyeloablative Allogeneic Transplant
Study Phase: Phase 2
A Phase I-II Open-label Study of UM171 Expanded Cord Blood in a Fed-batch Culture System (UFCB-001) in Patients Who Need an Allogeneic Hematopoietic Stem Cell Transplant But Lack a Suitable Donor
A Phase I-II Open-label Study of UM171 Expanded Cord Blood in a Fed-batch Culture System (UFCB-001) in Patients Who Need an Allogeneic Hematopoietic Stem Cell Transplant But Lack a Suitable Donor
Enrollment Status: Completed
Publish Date: August 05, 2019
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

41 Total Publications

A new era of complement inhibition: are we ready for the infectious risks?
A new era of complement inhibition: are we ready for the infectious risks?
Journal: Pediatric nephrology (Berlin, Germany)
Published: July 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Roy's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile